Value of APTT-based clot waveform analysis in calf muscular vein thrombosis and the assessment of anticoagulant efficacy
10.13303/j.cjbt.issn.1004-549x.2026.10.011
- VernacularTitle:基于APTT的凝固曲线波形分析在小腿肌肉静脉血栓形成及抗凝疗效评估中的应用价值
- Author:
Jingsong BAI
1
;
Linxin YU
2
;
Guo LI
1
;
Jian LIAO
1
;
Ying XU
3
Author Information
1. Department of Clinical Laboratory, The First Affiliated Hospital of Traditional Chinese Medicine of Chengdu Medical College, Xindu Hospital of Traditional Chinese Medicine/TCM Preventative Treatment Research Center of Chengdu Medical College, Chengdu 610500, China
2. Chengdu Medical College, Chengdu 610500, China
3. Department of Clinical Laboratory, The First Affiliated Hospital of Traditional Chinese Medicine of Chengdu Medical College, Xindu Hospital of Traditional Chinese Medicine/TCM Preventative Treatment Research Center of Chengdu Medical College, Chengdu 610500, China; Chengdu Medical College, Chengdu 610500, China; Department of Clinical Laboratory, First Affiliated Hospital of Chengdu Medical College, Chengdu 610500, China
- Publication Type:Journal Article
- Keywords:
calf muscle venous thrombosis;
clot waveform analysis;
fibrinogen;
anticoagulation efficacy monitoring;
orthopedic patients
- From:
Chinese Journal of Blood Transfusion
2026;39(10):1395-1403
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To evaluate the discriminatory value of activated partial thromboplastin time (APTT)-based clot waveform analysis (APTT-CWA) parameters in orthopaedic patients who develop calf muscular vein thrombosis (CMVT) despite prophylactic anticoagulation, and to explore their potential application in the assessment of anticoagulant efficacy. Methods: Patientshospitalized in the Department of Orthopaedics between March 2025 and June 2026 who had received prophylactic-dose anticoagulation with low-molecular-weight heparin or rivaroxaban and had elevated D-dimer levels, were included in this retrospective study. Based on bilateral lower-limb venous ultrasonography, 147 patients were divided into a CMVT-positive group (n=64) and a CMVT-negative group (n=83). In addition, 235 healthy individuals who underwent routine physical examination during the same period were enrolled as the healthy control group. Conventional coagulation parameters (PT, APTT, Fib, and D-D) as well as APTT-CWA parameters (CT, Min1, TMin1, Min2, Max2, TMax2, and Delta) and derived parameters (AUC-CWA, T-APTT, and Ad-Min1) were collected. Univariate and multivariate logistic regression analyses were used to identify risk factors for CMVT, and a multivariable ROC diagnostic model was constructed. A paired analysis of the dynamic changes in these parameters before and after anticoagulant therapy was performed in 25 patients from the positive group. Results: When the CMVT-positive group was compared with the negative group, only Max2 differed significantly [582.94 (486.05, 679.09) vs 528.80 (464.54, 599.51), P<0.05]. After correction by the Benjamini-Hochberg (FDR) method and the Bonferroni method, no between-group difference in Max2 was observed (adjusted q>0.05 and P>0.05), indicating that the discriminatory performance of a single parameter was limited. Univariate ROC curve analysis showed that Max2 had the highest AUC (0.606, 95% CI: 0.511-0.702). After adjustment for confounding factors, each 100 mAbs/s
increase in Max2 corresponded to an OR for CMVT of 1.49 (95% CI: 1.00-2.45, P=0.050); when expressed per 1 standard deviation (SD=163.3 mAbs/s
), the OR was 1.92 (95% CI: 1.00-4.32). VIF diagnostics showed that Min1, Delta, AUC-CWA, and T-APTT were severely collinear with Fib (R
=0.870, 0.858, 0.859, and 0.807; VIF=44.0, 20.4, 28.6, and 17.7, respectively), that Max2 showed moderate collinearity with Fib (R
=0.429, VIF=6.60), and that Ad-Min1 showed mild collinearity with Fib (R
=0.285, VIF=2.04). Multivariate logistic regression analysis showed that a multivariable model built on age, sex, and Fib as the baseline had an AUC of 0.632; after the sequential addition of conventional coagulation parameters (PT, APTT, and D-D), APTT-CWA parameters (CT, Min1, TMin1, Min2, Max2, TMax2, and Delta), and derived parameters (AUC-CWA, T-APTT, and Ad-Min1), the AUC increased to 0.642, 0.705, and 0.714, respectively, but none of the incremental differences was statistically significant (De-Long test, P>0.05). Although the AUC increased numerically, no statistically significant incremental value was demonstrated. After all APTT-CWA and derived parameters were included in the multivariable model, the apparent AUC increased to 0.714; however, after bootstrap correction the optimism-adjusted AUC decreased to 0.596, with an EPV of 4.0, suggesting a possible risk of overfitting. This model was therefore treated as an exploratory analysis only, and its performance still requires validation in an external cohort. After further variable optimization, a model incorporating age, Fib, Max2, and Ad-Min1 was constructed and showed better overall performance (AUC 0.648; adjusted AUC 0.609). In the 25 patients of the positive group, Min1, Min2, and T-APTT all decreased significantly after anticoagulant therapy (all P<0.05, with the same results after adjustment), whereas conventional PT and APTT showed no significant changes. During the subsequent 1-month follow-up, none of the patients showed thrombus progression. Conclusion: APTT-CWA parameters have limited discriminatory efficacy for CMVT that occurs in orthopaedic patients despite prophylactic anticoagulation, but may serve as a supplement to conventional coagulation indicators. Max2 and Ad-Min1 show relatively low collinearity with Fib and may therefore serve as potential kinetic detection indicators. In the assessment of anticoagulant efficacy, dynamic assessment of T-APTT holds potential application value.